Plasma asymmetric dimethylarginine in childhood asthma exacerbation

Background Asymmetric dimethylarginine (ADMA) is a new marker of inflammation in different inflammatory disorders. Bronchial asthma as a chronic disease of inflammatory nature is related to an expanded levels of numerous markers of inflammation which are used to assess the degree of severity of chil...

Full description

Bibliographic Details
Published in:Egyptian Journal of Chest Disease and Tuberculosis
Main Authors: Adel S Bediwy, Samir M Hassan, Salwa A Ganna, Marwa R El-Najjar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Subjects:
asthma
asthma exacerbation
asymmetric dimethylarginine
Online Access:http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2018;volume=67;issue=1;spage=46;epage=49;aulast=Bediwy

Internet

http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2018;volume=67;issue=1;spage=46;epage=49;aulast=Bediwy

Similar Items